Optipharm.CO.,LTD (KOSDAQ:153710)

Optipharm.CO.,LTD Statistics

Total Valuation

KOSDAQ:153710 has a market cap or net worth of KRW 76.58 billion. The enterprise value is 76.65 billion.

Market Cap	76.58B
Enterprise Value	76.65B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:153710 has 14.67 million shares outstanding. The number of shares has decreased by -0.19% in one year.

Current Share Class	14.67M
Shares Outstanding	14.67M
Shares Change (YoY)	-0.19%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.71%
Owned by Institutions (%)	n/a
Float	8.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.63
PB Ratio	2.94
P/TBV Ratio	2.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-32.42
EV / Sales	3.63
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.39

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.41.

Current Ratio	1.27
Quick Ratio	0.98
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	-2.31
Interest Coverage	-4.51

Financial Efficiency

Return on equity (ROE) is -9.48% and return on invested capital (ROIC) is -4.11%.

Return on Equity (ROE)	-9.48%
Return on Assets (ROA)	-3.53%
Return on Invested Capital (ROIC)	-4.11%
Return on Capital Employed (ROCE)	-8.02%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.50
Inventory Turnover	9.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.07% in the last 52 weeks. The beta is -0.04, so KOSDAQ:153710's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	-2.07%
50-Day Moving Average	5,172.80
200-Day Moving Average	5,147.30
Relative Strength Index (RSI)	48.98
Average Volume (20 Days)	12,737

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:153710 had revenue of KRW 21.09 billion and -2.36 billion in losses. Loss per share was -161.27.

Revenue	21.09B
Gross Profit	5.63B
Operating Income	-2.36B
Pretax Income	-2.36B
Net Income	-2.36B
EBITDA	-710.95M
EBIT	-2.36B
Loss Per Share	-161.27

Balance Sheet

The company has 10.75 billion in cash and 10.82 billion in debt, giving a net cash position of -70.44 million or -4.80 per share.

Cash & Cash Equivalents	10.75B
Total Debt	10.82B
Net Cash	-70.44M
Net Cash Per Share	-4.80
Equity (Book Value)	26.08B
Book Value Per Share	1,777.72
Working Capital	3.69B

Cash Flow

In the last 12 months, operating cash flow was -1.47 billion and capital expenditures -3.21 billion, giving a free cash flow of -4.68 billion.

Operating Cash Flow	-1.47B
Capital Expenditures	-3.21B
Free Cash Flow	-4.68B
FCF Per Share	-318.81

Margins

Gross margin is 26.70%, with operating and profit margins of -11.21% and -11.21%.

Gross Margin	26.70%
Operating Margin	-11.21%
Pretax Margin	-11.21%
Profit Margin	-11.21%
EBITDA Margin	-3.37%
EBIT Margin	-11.21%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:153710 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.19%
Shareholder Yield	n/a
Earnings Yield	-3.09%
FCF Yield	-6.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:153710 has an Altman Z-Score of 2.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.19
Piotroski F-Score	3